A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)	Metastatic Castration-resistant Prostate Cancer	Recruiting	Phase 1	2026-05-15		NCT07244341

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Bayer	178
Daiichi Sankyo	144

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beth Isreal Deaconess Medical Center	Boston	United States	6
Cancer & Hematology Center	Grand Rapids	United States	1
Cancer Institute Hospital of Jfcr	Kōtoku	Japan	11
Carolina Urologic Research Center	Myrtle Beach	United States	2
Dana Farber Cancer Institute	Newton	United States	1
Fudan University Shanghai Cancer Center	Shanghai	China	83
Fudan University Shanghai Cancer Center - Xuhui District	Shanghai	China	1
Kobe City Med Cen Gen Hosp.	Kobe	Japan	1
Mater Misericordiae University Hospital	Dublin	Ireland	12
Medical College of Wisconsin	Milwaukee	United States	9
National Cancer Center Hospital East	Kashiwa-shi	Japan	11
Next Oncology	San Antonio	United States	4
Northwell Health Cancer Institute (START NY)	Lake Success	United States	1
Shanghai General Hospital	Shanghai	China	28
Sun Yatsen University Cancer Center	Guangzhou	China	1
The First Affiliated Hospital of Wenzhou Medical University	Wenzhou	China	46
Toho University Sakura Medical Center	Sakura-shi	Japan	3
University of California San Diego Moores Cancer Center	La Jolla	United States	1
Virginia Cancer Specialists (NEXT Virginia)	Fairfax	United States	1